Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0AR7L
|
||||
| Former ID |
DIB005323
|
||||
| Drug Name |
SAR-389644
|
||||
| Synonyms |
SAR-389644C; Prostaglandin D2 antagonist (asthma/allergic rhinitis), sanofi-aventis
|
||||
| Indication | Allergic rhinitis [ICD9: 472.0, 477, 995.3; ICD10:J00, J30, J31.0, T78.4] | Phase 1 | [548481] | ||
| Company |
Sanofi
|
||||
| Target and Pathway | |||||
| Target(s) | Prostaglandin D2 receptor | Target Info | Antagonist | [550898] | |
| KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
| Pathway Interaction Database | Thromboxane A2 receptor signaling | ||||
| PathWhiz Pathway | Intracellular Signalling Through PGD2 receptor and Prostaglandin D2 | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.